Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

Clinical trial NCT03767738 · COMPLETED

Trial details

NCT number: NCT03767738
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chorioretinal Vascular Disease

Start date: 2018-12-19
Primary completion: 2020-08-19
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.